ISSN 1214-0287 (on-line), ISSN 1214-021X (printed)
J Appl Biomed
Volume 11 (2013), No 4, p 209-221
DOI 10.2478/v10136-012-0030-y

Relationship between serum bilirubin and uric acid to oxidative stress markers in Italian and Czech populations

Libor Vitek, Ladislav Novotny, Ales Zak, Barbora Stankova, Tomas Zima, Angela Polito, Greco Cesare, Chiara Zerbinati, Luigi Iuliano

Address: Libor Vitek, Institute of Medical Biochemistry and Laboratory Diagnostics, 1st Faculty of Medicine, Charles University in Prague, Na Bojisti 3, 120 00 Praha 2, Czech Republic
vitek@cesnet.cz

Received 31st October 2012.
Revised 14th December 2012.
Published online 19th December 2012.

Full text article (pdf)
Full text article (html)

SUMMARY
Recently, a South-to-North oxidative stress marker gradient has been reported; consistent with known differences in the incidence of coronary heart disease between southern and northern European countries. The aim of the present study was to compare the plasma concentrations of 7-oxocholesterol (7OxCH) and 7beta-hydroxycholesterol (7BCH) with systemic antioxidants in healthy Italian and Czech subjects. The study was performed in healthy subjects of Italian (n=131) and Czech (n=84) origins. In all subjects routine biochemistry work-ups were performed; additionally, plasma oxysterols and the peroxyl radicals scavenging activity (PERSA) of the sera were determined. Close relationship of serum bilirubin and uric acid to markers of oxidative stress was observed in both examined populations. Compared to the Czechs, the Italian population showed higher plasma concentrations of both oxysterols (7OxCH: 3.6 vs. 6.0 ng/mL, p<10-6; 7BCH: 5.3 vs. 8.6 ng/mL, p<10-6), lower PERSA (p<10-6), and lower serum concentrations of bilirubin and uric acid (p<10-6 in both cases). The dietary patterns of the Italian population did not match the Mediterranean style, but was more similar to the Continental type of diet, presumably due to non-adherence to a Mediterranean diet.

KEY WORDS
oxidative stress; oxysterols; bilirubin; uric acid; Mediterranean diet

REFERENCES
Alkazemi D, Egeland G, Vaya J, Meltzer S, Kubow S. Oxysterol as a marker of atherogenic dyslipidemia in adolescence. J Clin Endocrinol Metab. 93: 4282-4289, 2008.
[CrossRef] [PubMed]

Bach-Faig A, Berry EM, Lairon D, Reguant J, Trichopoulou A, Dernini S, Medina FX, Battino M, Belahsen R, Miranda G, Serra-Majem L; Mediterranean Diet Foundation Expert Group. Mediterranean diet pyramid today. Science and cultural updates. Public Health Nutr. 14: 2274-2284, 2011.
[CrossRef] [PubMed]

Beevers DG, Lip GY. Is uric acid really an independent cardiovascular risk factor? Lancet. 352: 1556, 1998.
[CrossRef]

Binkin N, Fontana G, Lamberti A, Cattaneo C, Baglio G, Perra A, Spinelli A. A national survey of the prevalence of childhood overweight and obesity in Italy. Obes Rev. 11: 2-10, 2010.
[CrossRef] [PubMed]

Bjorkhem I, Diczfalusy U. Oxysterols: friends, foes, or just fellow passengers? Arterioscler Thromb Vasc Biol. 22: 734-742, 2002.
[CrossRef] [PubMed]

Boon AC, Hawkins CL, Bisht K, Coombes JS, Bakrania B, Wagner KH, Bulmer AC. Reduced circulating oxidized LDL is associated with hypocholesterolemia and enhanced thiol status in Gilbert syndrome. Free Rad Biol Med. 52: 2120-2127, 2012.
[CrossRef] [PubMed]

Bulmer AC, Blanchfield JT, Toth I, Fassett RG, Coombes JS. Improved resistance to serum oxidation in Gilbert's syndrome: A mechanism for cardiovascular protection. Atherosclerosis. 199: 390-396, 2008.
[CrossRef] [PubMed]

Cifkova R, Skodova Z, Bruthans J, Adamkova V, Jozifova M, Galovcova M, Wohlfahrt P, Krajcoviechova A, Poledne R, Stavek P, Lanska V. Longitudinal trends in major cardiovascular risk factors in the Czech population between 1985 and 2007/8. Czech MONICA and Czech post-MONICA. Atherosclerosis. 211: 676-681, 2010.
[CrossRef] [PubMed]

Culleton BF, Larson MG, Kannel WB, Levy D. Serum uric acid and risk for cardiovascular disease and death: the Framingham Heart Study. Ann Intern Med. 131: 7-13, 1999.
[PubMed]

Frei B, Stocker R, Ames BN. Antioxidant defenses and lipid peroxidation in human blood plasma. Proc Natl Acad Sci USA. 85: 9748-9752, 1988.
[CrossRef] [PubMed]

Gagliardi AC, Miname MH, Santos RD. Uric acid: A marker of increased cardiovascular risk. Atherosclerosis. 202: 11-17, 2009.
[CrossRef] [PubMed]

Gelissen IC, Brown AJ, Mander EL, Kritharides L, Dean RT, Jessup W. Sterol efflux is impaired from macrophage foam cells selectively enriched with 7-ketocholesterol. J Biol Chem. 271: 17852-17860, 1996.
[CrossRef] [PubMed]

Gopinathan V, Miller NJ, Milner AD, Rice Evans CA. Bilirubin and ascorbate antioxidant activity in neonatal plasma. FEBS Lett. 349: 197-200, 1994.
[CrossRef]

Grau M, Guxens M, Subirana I, Fito M, Covas MI, Jacquemin B, Sunyer J, Lanki T, Picciotto S, Bellander T, Katsouyanni K, Schneider A et al. South-to-North gradient in lipid peroxidation in men with stable coronary artery disease in Europe. Eur Heart J. 28: 2841-2849, 2007.
[CrossRef] [PubMed]

Hammerman C, Goldstein R, Kaplan M, Eran M, Goldschmidt D, Eidelman AI, Gartner LM. Bilirubin in the premature: Toxic waste or natural defense? Clin Chem. 44: 2551-2553, 1998.
[PubMed]

Horsfall LJ, Rait G, Walters K, Swallow DM, Pereira SP, Nazareth I, Petersen I. Serum bilirubin and risk of respiratory disease and death. J Am Med Assoc. 305: 691-697, 2011.
[CrossRef] [PubMed]

Iribarren C, Folsom AR, Eckfeldt JH, McGovern PG, Nieto FJ. Correlates of uric acid and its association with asymptomatic carotid atherosclerosis: the ARIC Study. Atherosclerosis Risk in Communities. Ann Epidemiol. 6: 331-340, 1996.
[CrossRef]

Iuliano L. The oxidant stress hypothesis of atherogenesis. Lipids. 36 Suppl: S41-S44, 2001.
[CrossRef] [PubMed]

Iuliano L. Pathways of cholesterol oxidation via non-enzymatic mechanisms. Chem Phys Lipids. 164: 457-468, 2011.
[CrossRef]

Iuliano L, Piccheri C, Coppola I, Pratico D, Micheletta F, Violi F. Fluorescence quenching of dipyridamole associated to peroxyl radical scavenging: a versatile probe to measure the chain breaking antioxidant activity of biomolecules. Biochim Biophys Acta. 1474: 177-182, 2000.
[CrossRef]

Iuliano L, Micheletta F, Natoli S, Ginanni C, Iappelli M, Elisei W, Giovannelli L, Violi F, Diczfalusy U. Measurement of oxysterols and alpha-tocopherol in plasma and tissue samples as indices of oxidant stress status. Anal Biochem. 312: 217-223, 2003.
[CrossRef]

Jiraskova A, Novotny J, Novotny L, Vodicka P, Pardini B, Naccarati A, Schwertner HA, Hubacek JA, Puncocharova L, Smerhovský Z, Vitek L. Association of serum bilirubin and promoter variations in HMOX1 and UGT1A1 genes with sporadic colorectal cancer. Int J Cancer. 131: 1549-1555, 2012.
[CrossRef] [PubMed]

Kafatos A, Diacatou A, Voukiklaris G, Nikolakakis N, Vlachonikolis J, Kounali D, Mamalakis G, Dontas AS. Heart disease risk-factor status and dietary changes in the Cretan population over the past 30 y: the Seven Countries Study. Am J Clin Nutr. 65: 1882-1886, 1997.
[PubMed]

Keys A, Menotti A, Karvonen MJ, Aravanis C, Blackburn H, Buzina R, Djordjevic BS, Dontas AS, Fidanza F, Keys MH et al. The diet and 15-year death rate in the seven countries study. Am J Epidemiol. 124: 903-915, 1986.
[PubMed]

Lanti M, Menotti A, Nedeljkovic S, Nissinen A, Kafatos A, Kromhout D. Long-term trends in major cardiovascular risk factors in cohorts of aging men in the European cohorts of the Seven Countries Study. Aging Clin Exp Res. 17: 306-315, 2005.
[PubMed]

Larsson H, Bottiger Y, Iuliano L, Diczfalusy U. In vivo interconversion of 7beta-hydroxycholesterol and 7-ketocholesterol, potential surrogate markers for oxidative stress. Free Radic Biol Med. 43: 695-701, 2007.
[CrossRef] [PubMed]

Lin JP, Vitek L, Schwertner HA. Serum Bilirubin and Genes Controlling Bilirubin Concentrations as Biomarkers for Cardiovascular Disease. Clin Chem. 56: 1535-1543, 2010.
[CrossRef] [PubMed]

Maruhashi T, Soga J, Fujimura N, Idei N, Mikami S, Iwamoto Y, Kajikawa M, Matsumoto T, Kihara Y, Chayama K, Noma K, Nakashima A et al. Hyperbilirubinemia, augmentation of endothelial function and decrease in oxidative stress in Gilbert syndrome. Circulation. 126: 598-603, 2012.
[CrossRef] [PubMed]

Menotti A, Lanti M, Puddu PE, Kromhout D. Coronary heart disease incidence in northern and southern European populations: a reanalysis of the seven countries study for a European coronary risk chart. Heart. 84: 238-244, 2000.
[CrossRef] [PubMed]

Micheletta F, Natoli S, Misuraca M, Sbarigia E, Diczfalusy U, Iuliano L. Vitamin e supplementation in patients with carotid atherosclerosis - Reversal of altered oxidative stress status in plasma but not in plaque. Arterioscl Thromb Vasc Biol. 24: 136-140, 2004.
[CrossRef] [PubMed]

Nieto FJ, Iribarren C, Gross MD, Comstock GW, Cutler RG. Uric acid and serum antioxidant capacity: a reaction to atherosclerosis? Atherosclerosis. 148: 131-139, 2000.
[CrossRef]

Novotny L, Vitek L. Inverse relationship between serum bilirubin and atherosclerosis in men: a meta-analysis of published studies. Exp Biol Med (Maywood). 228: 568-571, 2003.
[PubMed]

Stocker R, Keaney JF. Role of oxidative modifications in atherosclerosis. Physiol Rev. 84: 1381-1478, 2004.
[CrossRef] [PubMed]

Tapan S, Karadurmus N, Dogru T, Ercin CN, Tasci I, Bilgi C, Kurt I, and Erbil MK. Decreased small dense LDL levels in Gilbert's syndrome. Clin Biochem. 44: 300-303, 2011.
[CrossRef] [PubMed]

Traber MG, Jialal I. Measurement of lipid-soluble vitamins - further adjustment needed? Lancet. 355: 2013-2014, 2000.
[CrossRef]

Trichopoulou A, Costacou T, Bamia C, Trichopoulos D. Adherence to a Mediterranean diet and survival in a Greek population. N Engl J Med. 348: 2599-2608, 2003.
[CrossRef] [PubMed]

Tsimikas S, Mallat Z, Talmud PJ, Kastelein JJ, Wareham NJ, Sandhu MS, Miller ER, Benessiano J, Tedgui A, Witztum JL, Khaw KT, Boekholdt SM. Oxidation-specific biomarkers, lipoprotein(a), and risk of fatal and nonfatal coronary events. J Am Coll Cardiol. 56: 946-955, 2010.
[CrossRef] [PubMed]

Vejux A, Lizard G. Cytotoxic effects of oxysterols associated with human diseases: Induction of cell death (apoptosis and/or oncosis), oxidative and inflammatory activities, and phospholipidosis. Mol Aspects Med. 30: 153-170, 2009.
[CrossRef] [PubMed]

Vitek L, Schwertner HA. The heme catabolic pathway and its protective effects on oxidative stress-mediated diseases. Adv Clin Chem. 43: 1-57, 2007.
[CrossRef]

Vitek L, Jirsa M, Brodanova M, Kalab M, Marecek Z, Danzig V, Novotny L, Kotal P. Gilbert syndrome and ischemic heart disease: a protective effect of elevated bilirubin levels. Atherosclerosis. 160: 449-456, 2002.
[CrossRef]

Yano K, Reed DM, Mcgee DL. 10-Year Incidence of Coronary Heart-Disease in the Honolulu Heart Program - Relationship to Biologic and Lifestyle Characteristics. Am J Epidemiol. 119: 653-666, 1984.
[PubMed]

Yeum KJ, Russell RM, Krinsky NI, Aldini G. Biomarkers of antioxidant capacity in the hydrophilic and lipophilic compartments of human plasma. Arch Biochem Biophys. 430: 97-103, 2004.
[CrossRef] [PubMed]

Zucker SD, Horn PS, Sherman KE. Serum bilirubin levels in the US population: Gender effect and inverse correlation with colorectal cancer. Hepatology. 40: 827-835, 2004.
[PubMed]
CITED

0


BACK